Larvol Delta - Aligos-Therapeutics-Announces-the-Completion-of-Enrollment-in-the-ALG055009-Phase-2a-HERALD-Study-for-the-Treatment-of-MASH

ALG-055009 - Aligos Therap

https://ca.finance.yahoo.com/news/aligos-therapeutics-announces-completion-enrollment-120000346.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAANhCdYqGW95MbgvY6F_0Dw7KungRl_qg2oiegJNkbvhHEBO59OQiWI_jb5nwAn9mWlSEBAr7_yqcnBhy5XWF9nfEHRmgekZBa6tU1RwTn3G8dhDIjAGrTAGCzifTxjp7-X3lWUaGpB3uLlWZiBgAa0IAA5n9_3Mp8rr9dC4oVC5b

May 21, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next